Cardiac glycosides pharmaceutical consumption in Spain 2004-2017
This statistic displays the consumption of cardiac glycosides in Spain from 2004 to 2017. In 2017, the defined daily dosage of cardiac glycosides in Spain amounted to 2.6 per 1,000 inhabitants per day.
Welcome to Statista!
We are the global leading platform for business data from 600 industries and 50 countries.
Consumption of cardiac glycosides per 1,000 inhabitants per day in Spain from 2004 to 2017
Loading statistic...
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account!
Premium Account
Your perfect start with Statista
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$49 / Month *
Corporate Account
Full access
Corporate solution including all features.
* All products require an annual contract.
Prices do not include sales tax.
Prices do not include sales tax.
Leading companies trust Statista:
I think of Statista as Google for researchers. Statista provides you with the information you search for right away.Dr. Horst Stipp
EVP, Research & Innovation, Advertising Research Foundation
Discover Statista
Need help with using Statista for your research?
Tutorials and first steps
Further Content: Statistics, Studies, and Topic Pages
Statistics
- Pharmaceutical consumption of antiinfectives for systemic use in Spain 2004-2017
- Antidepressants pharmaceutical consumption in Spain 2004-2017
- Alimentary tract and metabolism pharmaceutical consumption in Finland 2005-2016
- Lipid-modifying agents pharmaceutical consumption in Spain 2004-2017
- Calcium channel blockers pharmaceutical consumption in Spain 2004-2017
- Respiratory system drugs consumption in Spain 2004-2017
- Nervous system drugs consumption in Spain 2004-2017
- Alimentary tract and metabolism pharmaceutical consumption in the UK 2005-2016
- Anxiolytics pharmaceutical consumption in Spain 2004-2017
- Pharmaceutical consumption of drugs acting on the alimentary tract in Spain 2004-2017
- Cardiovascular system drugs consumption in Spain 2004-2017
Studies
- Pharmaceutical industry in the Netherlands
- Pharmaceutical trends in Europe
- Oncology
- CDER New Drugs Program: 2018 Update
- CDER 2018 New Drug Therapy Approvals
- Personalized medicine
- CDER 2017 New Drug Therapy Approvals
- CDER New Drugs Program: 2017 Update
- Zoetis Annual Report 2018
- CDER New Drug Review: 2016 Update
- PAGB Annual Review 2017-2018
- Top 200 Products in the US Market by Sales, 2009
Further related statistics
OECD. (July 2, 2019). Consumption of cardiac glycosides per 1,000 inhabitants per day in Spain from 2004 to 2017 [Graph]. In Statista. Retrieved October 23, 2019, from https://www.statista.com/statistics/782365/cardiac-glycosides-pharmaceutical-consumption-spain/
OECD. "Consumption of cardiac glycosides per 1,000 inhabitants per day in Spain from 2004 to 2017." Chart. July 2, 2019. Statista. Accessed October 23, 2019. https://www.statista.com/statistics/782365/cardiac-glycosides-pharmaceutical-consumption-spain/
OECD. (2019). Consumption of cardiac glycosides per 1,000 inhabitants per day in Spain from 2004 to 2017. Statista. Statista Inc.. Accessed: October 23, 2019. https://www.statista.com/statistics/782365/cardiac-glycosides-pharmaceutical-consumption-spain/
OECD. "Consumption of Cardiac Glycosides per 1,000 Inhabitants per Day in Spain from 2004 to 2017." Statista, Statista Inc., 2 Jul 2019, https://www.statista.com/statistics/782365/cardiac-glycosides-pharmaceutical-consumption-spain/
OECD, Consumption of cardiac glycosides per 1,000 inhabitants per day in Spain from 2004 to 2017 Statista, https://www.statista.com/statistics/782365/cardiac-glycosides-pharmaceutical-consumption-spain/ (last visited October 23, 2019)